Efficacy of combined CDK9/BET inhibition in preclinical models of MLL-rearranged acute leukemia

Cyclin-dependent kinase 9 and bromodomain and extraterminal inhibitors are synergistic in MLL-rearranged leukemia. Multiple AML driver genes are downregulated by the combined therapy suggesting broad applicability for this subtype.

Enregistré dans:
Détails bibliographiques
Publié dans:Blood Adv
Auteurs principaux: McCalmont, Hannah, Li, Ka Leung, Jones, Luke, Toubia, John, Bray, Sarah C., Casolari, Debora A., Mayoh, Chelsea, Samaraweera, Saumya E., Lewis, Ian D., Prinjha, Rab K., Smithers, Nicholas, Wang, Shudong, Lock, Richard B., D’Andrea, Richard J.
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2020
Sujets:
Stimulus Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6988396/
https://ncbi.nlm.nih.gov/pubmed/31971998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000586
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires